[1]
Michał Bzoma, “GLP-1 RECEPTOR AGONISTS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: THERAPEUTIC POTENTIAL AND CLINICAL CHALLENGES”, IJITSS, no. 3(47), Jul. 2025.